Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthi Petrou

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Current Topics in Medicinal Chemistry|February 5, 2019
PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type IIPhaedra Eleftheriou, Athina Geronikaki, Anthi Petrou
Molecules (Basel, Switzerland)|June 2, 2021
Thiazole Ring-A Biologically Active ScaffoldAnthi Petrou, Maria Fesatidou, Athina Geronikaki
Current Pharmaceutical Design|February 7, 2020
Heterocycle Compounds with Antimicrobial ActivityMaria Fesatidou, Anthi Petrou, Geronikaki Athina
Chemistry & Biodiversity|October 23, 2024
Design, Synthesis, Biological Evaluation and Molecular Docking Studies of New Thiazolidinone Derivatives as NNRTIs and SARS-CoV-2 Main Protease InhibitorsMaria Fesatidou, Anthi Petrou, Athina Geronikaki
Molecules (Basel, Switzerland)|June 4, 2020
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 VirusPhaedra Eleftheriou, Dionysia Amanatidou, Anthi Petrou, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Τhiazolidine-4-One Derivatives with Variable Modes of Inhibitory Action Against DPP4, a Drug Target with Multiple Activities and Established Role in Diabetes Mellitus Type IIDionysia Amanatidou, Phaedra Eleftheriou, Anthi Petrou, et al.
Molecules (Basel, Switzerland)|October 27, 2019
Novel Thiazolidin-4-ones as Potential Non-nucleoside Inhibitors of HIV-1 Reverse TranscriptaseAnthi Petrou, Phaedra Eleftheriou, Athina Geronikaki, et al.
International Journal of Molecular Sciences|September 14, 2024
Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic ApproachesOlga Tarasova, Anthi Petrou, Sergey M Ivanov, et al.
Current Topics in Medicinal Chemistry|December 15, 2020
Thiazole-based Chalcone Derivatives as Potential Anti-inflammatory Agents: Biological Evaluation and Molecular ModellingChristophe Tratrat, Michelyne Haroun, Evangelia Tsolaki, et al.
European Journal of Medicinal Chemistry|September 2, 2020
Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitusAntonios Kousaxidis, Anthi Petrou, Vasiliki Lavrentaki, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Current Topics in Medicinal Chemistry|February 5, 2019
PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type IIPhaedra Eleftheriou, Athina Geronikaki, Anthi Petrou
Molecules (Basel, Switzerland)|June 2, 2021
Thiazole Ring-A Biologically Active ScaffoldAnthi Petrou, Maria Fesatidou, Athina Geronikaki
Current Pharmaceutical Design|February 7, 2020
Heterocycle Compounds with Antimicrobial ActivityMaria Fesatidou, Anthi Petrou, Geronikaki Athina
Chemistry & Biodiversity|October 23, 2024
Design, Synthesis, Biological Evaluation and Molecular Docking Studies of New Thiazolidinone Derivatives as NNRTIs and SARS-CoV-2 Main Protease InhibitorsMaria Fesatidou, Anthi Petrou, Athina Geronikaki
Molecules (Basel, Switzerland)|June 4, 2020
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 VirusPhaedra Eleftheriou, Dionysia Amanatidou, Anthi Petrou, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Τhiazolidine-4-One Derivatives with Variable Modes of Inhibitory Action Against DPP4, a Drug Target with Multiple Activities and Established Role in Diabetes Mellitus Type IIDionysia Amanatidou, Phaedra Eleftheriou, Anthi Petrou, et al.
Molecules (Basel, Switzerland)|October 27, 2019
Novel Thiazolidin-4-ones as Potential Non-nucleoside Inhibitors of HIV-1 Reverse TranscriptaseAnthi Petrou, Phaedra Eleftheriou, Athina Geronikaki, et al.
International Journal of Molecular Sciences|September 14, 2024
Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic ApproachesOlga Tarasova, Anthi Petrou, Sergey M Ivanov, et al.
Current Topics in Medicinal Chemistry|December 15, 2020
Thiazole-based Chalcone Derivatives as Potential Anti-inflammatory Agents: Biological Evaluation and Molecular ModellingChristophe Tratrat, Michelyne Haroun, Evangelia Tsolaki, et al.
European Journal of Medicinal Chemistry|September 2, 2020
Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitusAntonios Kousaxidis, Anthi Petrou, Vasiliki Lavrentaki, et al.
Pageof 8